Hence, further research is necessary in order to evaluate (a) the feasibility of delivery of GAPDH-shRNA under Ultra-sound guidance to target GAPDH in an orthotopic liver tumor model and (b) the molecular specificity of AFP-dependent silencing of GAPDH in HCC. The gene discussed is GAPDH; the disease is hepatocellular carcinoma.